
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease ... Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH). Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.0829 | 0.0829 | 0.0829 | 0 | 0 | CS |
4 | -0.0451 | -35.234375 | 0.128 | 0.142 | 0.057 | 1244080 | 0.09516989 | CS |
12 | -0.3081 | -78.7979539642 | 0.391 | 0.414899 | 0.057 | 1307662 | 0.13743546 | CS |
26 | -0.3931 | -82.5840336134 | 0.476 | 0.574 | 0.057 | 946823 | 0.23100654 | CS |
52 | -0.6572 | -88.7988109715 | 0.7401 | 0.7689 | 0.057 | 688391 | 0.32767211 | CS |
156 | -1.3771 | -94.3219178082 | 1.46 | 5.95 | 0.057 | 534743 | 1.2691971 | CS |
260 | -16.9171 | -99.5123529412 | 17 | 35.6 | 0.057 | 586369 | 2.8420067 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.